Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens

by Weerawat Manosuthi, Wiroj Mankatitham, Aroon Lueangniyomkul, Wisit Prasithsirikul, Preecha Tantanathip, Busakorn Suntisuklappon, Anongnuch Narkksoksung, Samruay Nilkamhang, Somnuek Sungkanuparph
Published 2018

Metabolic benefits of switching to tenofovir/lamivudine after long-term use of stavudine/lamivudine in NNRTI-based antiretroviral regimens: A prospective study

by Weerawat Manosuthi, Aroon Lueangniyomkul, Wiroj Mankatitham, Sukanya Chimsuntorn, Preecha Tantanathip, Supeda Thongyen, Busakorn Suntisuklappon, Samruay Nilkamhang, Somnuek Sungkanuparph
Published 2018

Time to initiate antiretroviral therapy between 4 weeks and 12 weeks of tuberculosis treatment in HIV-infected patients: Results From the TIME study

by Weerawat Manosuthi, Wiroj Mankatitham, Aroon Lueangniyomkul, Supeda Thongyen, Sirirat Likanonsakul, Pawita Suwanvattana, Unchana Thawornwan, Busakorn Suntisuklappon, Samruay Nilkamhang, Somnuek Sungkanuparph
Published 2018